Predictors of chronic heart failure development and progression in pre-dialysis patients with chronic kidney disease
Journal Title: Нирки - Year 2019, Vol 8, Issue 1
Abstract
Chronic kidney disease leads to early damage to the heart and blood vessels with the development of heart failure. The manifestation of one disease leads to the progression of another, since chronic heart failure is a condition in which the myocardium and kidneys are pathogenetically closely related to each other. The purpose of the work was to identify early predictors of chronic heart failure development and progression in patients with chronic kidney disease. Materials and methods. A retrospective analysis of case histories of 322 patients with chronic kidney disease stages 1–4 was carried out. Patients were divided into two groups: the main group included those with chronic kidney disease and chronic heart failure (n = 50), the comparison group — patients with chronic kidney disease, but without chronic heart failure (n = 50). We studied the data of clinical, laboratory and instrumental examination. The obtained results were processed statistically. Results. Patients with chronic kidney disease and signs of heart failure had an increased body mass index, leg swelling, and stage 2 hypertension degrees 1–2. The electrocardiograpy revealed a rhythm disturbance by the type of paroxysmal tachycardia and atrial fibrillation. A decrease in hemoglobin level, filtration function of the kidneys, as well as manifestations of dyslipidemia were detected. Conclusions. Diastolic hypertension, anemia and increased total cholesterol can be considered as early predictors of chronic heart failure in patients with chronic kidney disease. Consequently, the risk of heart failure development and progression increases with a decrease in glomerular filtration rate below 60 ml/min. Chronic heart failure develops earlier and progresses faster in patients with chronic kidney disease that developed as a result of chronic glomerulonephritis.
Authors and Affiliations
V. V. Rodionova, O. O. Boyko, O. A. Turenko
Keywords
Related Articles
- EP ID EP473986
- DOI 10.22141/2307-1257.8.1.2019.157793
- Views 83
- Downloads 0
Immunoadsorption and Its Application for Desensitizing Incompatible Kidney Transplant Candidates Who Have a Potential Living Donor
Background. Plasmapheresis is widely used to remove potential deleterious antibodies from the blood. Because the volume of treated plasma is limited, plasmapheresis can be replaced by immunoadsorption (IA), a more tediou...
Calcium and Phosphorus Metabolism in Chronic Kidney Disease
.
The use of ceruloplasmin drugs for correction of anemia and intoxication in patients with chronic kidney disease
Anemia - reduction of the total number of erythrocytes and / or hemoglobin in the blood volume unit. Ceruloplasmin drugs are using for stimulation of hematopoiesis, detoxication (reduction of intoxication), immune recons...
Predictors of chronic heart failure development and progression in pre-dialysis patients with chronic kidney disease
Chronic kidney disease leads to early damage to the heart and blood vessels with the development of heart failure. The manifestation of one disease leads to the progression of another, since chronic heart failure is a co...
The correlation between renal functional reserve and serum uric acid and quality of life in chronic kidney disease stage I–III
Background. In clinical practice the renal functional reserve can be an important tool to identify the early kidney functional damage, cure them and impact diseases prognosis. The aim of this article was to review the co...